Effect of Colesevelam HCl (COL) as an Add-On to Pioglitazone (PIO) on Lipid Particles in Type 2 Diabetes Mellitus (T2DM)

被引：0
|
作者：
Jones, Michael R.
Ford, Daniel M.
Baz-Hecht, Merav
Tao, Ben
Truitt, Kenneth E.
Chou, Hubert S.
机构：
来源：
DIABETES | 2013年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1161-P
引用
收藏
页码：A302 / A302
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of Colesevelam HCl (COL) as an Add-On to Pioglitazone (PIO) for Type 2 Diabetes Mellitus (T2DM)
    Ford, Daniel M.
    Baz-Hecht, Merav
    Said, Nabil A.
    Tao, Ben
    Truitt, Kenneth E.
    Chou, Hubert S.
    [J]. DIABETES, 2013, 62 : A273 - A273
  • [2] Effect of Colesevelam HCl Monotherapy on Lipid Particles in Type 2 Diabetes Mellitus
    Robert S. Rosenson
    Scott P. Rigby
    Michael R. Jones
    Hubert S. Chou
    [J]. Cardiovascular Drugs and Therapy, 2014, 28 : 229 - 236
  • [3] Effect of Colesevelam HCl Monotherapy on Lipid Particles in Type 2 Diabetes Mellitus
    Rosenson, Robert S.
    Rigby, Scott P.
    Jones, Michael R.
    Chou, Hubert S.
    [J]. CARDIOVASCULAR DRUGS AND THERAPY, 2014, 28 (03) : 229 - 236
  • [4] Colesevelam HCl reduces postprandial glucose in patients with type 2 diabetes mellitus (T2DM)
    Zieve, Franklin
    Schwartz, Sherwyn L.
    Kalin, Marcia
    Jones, Michael R.
    [J]. DIABETES, 2006, 55 : A140 - A140
  • [5] Pioglitazone (PIO) enhances insulin sensitivity (IS) in patients with type 2 diabetes (T2DM)
    Johns, D
    Herz, M
    Tan, MH
    Robertson, KE
    Gonzalez, B
    Reviriego, J
    Grossman, LD
    [J]. DIABETES, 2002, 51 : A102 - A102
  • [6] Vildagliptin as add-on to insulin in patients with type 2 diabetes (T2DM)
    Fonseca, Vivian
    Dejager, Sylvie
    Albrecht, Diego
    Shirt, Lynda
    Schweizer, Anja
    [J]. DIABETES, 2006, 55 : A111 - A111
  • [7] Empagliflozin (EMPA) for ≥76 Weeks As Add-on to Pioglitazone with or without Metformin in Patients with Type 2 Diabetes (T2DM)
    Kovacs, Christopher Simon
    Seshiah, Veeraswamy
    Merker, Ludwig
    Christiansen, Anita Vedel
    Roux, Flavien
    Salsali, Afshin
    Kim, Gabriel
    Stella, Peter
    Woerle, Hans-Juergen
    Broedl, Uli C.
    [J]. ENDOCRINE REVIEWS, 2014, 35 (03)
  • [8] Empagliflozin as Add-On to Pioglitazone With or Without Metformin Improves Glycemic Control in Patients With Type 2 Diabetes (T2DM)
    Kovacs, Christopher
    Seshiah, Veeraswamy
    Swallow, Ros
    Jones, Russell
    Rattunde, Henning
    Woerle, Hans J.
    Broedl, Uli C.
    [J]. DIABETES, 2013, 62 : A291 - A291
  • [9] Empagliflozin (EMPA) for ≥76 Weeks as Add-on to Pioglitazone With or Without Metformin in Patients with Type 2 Diabetes (T2DM)
    Kovacs, Christopher S.
    Seshiah, Veeraswamy
    Merker, Ludwig
    Christiansen, Anita Vedel
    Roux, Flavien
    Salsali, Afshin
    Kim, Gabriel
    Stella, Peter
    Woerle, Hans J.
    Broedl, Uli C.
    [J]. DIABETES, 2014, 63 : A273 - A273
  • [10] Effects of Extended Pioglitazone Treatment (PIO) on Bone Metabolism in Patients with Prediabetes and Type 2 Diabetes Mellitus (T2DM)
    Sanchez, Paola Portillo
    Bril, Fernando
    Lomonaco, Romina
    Maximos, Maryann
    Bruder, Jan
    Orsak, Beverly
    Hecht, Joan
    Cusi, Kenneth
    [J]. DIABETES, 2014, 63 : A293 - A294
12345